Lucintel forecasts that the coronary stent segment will show above average growth during the forecast period due to increasing cases of cardiovascular disorders. #StentMarket, #Stent
2. Industry Profiles Snapshot
Major Parameter Description
Market Segments by Product
Type
Coronary stent and peripheral vascular stent
Market Segments by Material Metal and polymer
Market Segments by
Technology
Bare metal stent, drug eluting stent, and bioreabsorbable stent
Market Segments by End Use Hospital and ambulatory surgical center
Market Segments by Region North America, Europe, Asia Pacific and Rest of the World.
Top Companies Name
Abbott Laboratory, Boston Scientific, Medtronic public limited company, C R
Bard, Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc. and
others.
Trend Growth Rate and CAGR 3.3%
Key Industry Forecast
The global stent market is expected to reach an estimated $10.8 billion by
2024 with a CAGR of 3.3% from 2019 to 2024
Key Industry Driver
Driver: Increasing interventional cardiology and peripheral vascular
procedures and rising adoption of technological advancements in an effort to
reduce treatment duration for high risk conventional surgical patients.
2
3. Industry Overview
Market Size
• The global stent market is expected to
reach an estimated $10.8 billion by 2024
with a CAGR of 3.3% from 2019 to 2024
• Emerging trends which have a direct impact on
the dynamics of the stent market include
increasing use of bioreabsorbable stent,
increasing adoption of co-polymers as raw
materials, and increasing adoption of
bifurcated stents.
Market Size (2024) $10.8 billion
CAGR (2019-24) 3.3%
3
Industry Performance : Forecast